Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Detection of Rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage.

Shibata W, Niki M, Sato K, Fujimoto H, Yamada K, Watanabe T, Miyazaki Y, Asai K, Obata Y, Tachibana T, Kawaguchi T, Kaneko Y, Kakeya H.

Med Mycol. 2020 Feb 14. pii: myaa001. doi: 10.1093/mmy/myaa001. [Epub ahead of print]

PMID:
32060526
2.

Cryptic Chemical Communication: Secondary Metabolic Responses Revealed by Microbial Co-culture.

Liu C, Kakeya H.

Chem Asian J. 2020 Feb 3;15(3):327-337. doi: 10.1002/asia.201901505. Epub 2020 Jan 20. Review.

PMID:
31957936
3.

Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.

Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.

Intern Med. 2020;59(2):193-198. doi: 10.2169/internalmedicine.3358-19. Epub 2020 Jan 15.

4.

Effect of four neuraminidase inhibitors on influenza in Osaka, Japan: An eight-year survey.

Tochino Y, Yoshii N, Fujioka M, Hamazaki T, Kawaguchi T, Kakeya H, Shuto T.

J Gen Fam Med. 2019 Oct 31;21(1):18-23. doi: 10.1002/jgf2.286. eCollection 2020 Jan.

5.

Different localization of lysosomal-associated membrane protein 1 (LAMP1) in mammalian cultured cell lines.

Baba K, Kuwada S, Nakao A, Li X, Okuda N, Nishida A, Mitsuda S, Fukuoka N, Kakeya H, Kataoka T.

Histochem Cell Biol. 2020 Jan 6. doi: 10.1007/s00418-019-01842-z. [Epub ahead of print]

PMID:
31907597
6.

Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus.

Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Kakeya H, Yamakage H, Satoh-Asahara N, Wada H, Hasegawa K, Morimoto T.

J Diabetes Res. 2019 Nov 23;2019:8208237. doi: 10.1155/2019/8208237. eCollection 2019.

7.

Ubiquitin carboxyl-terminal hydrolase L1 promotes hypoxia-inducible factor 1-dependent tumor cell malignancy in spheroid models.

Li X, Hattori A, Takahashi S, Goto Y, Harada H, Kakeya H.

Cancer Sci. 2020 Jan;111(1):239-252. doi: 10.1111/cas.14236. Epub 2019 Dec 10.

8.

Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.

Namikawa H, Niki M, Niki M, Yamada K, Nakaie K, Sakiyama A, Oinuma KI, Tsubouchi T, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2291-2297. doi: 10.1007/s10096-019-03676-y. Epub 2019 Oct 11.

PMID:
31605255
9.

Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.

Miyazaki T, Yanagihara K, Kakeya H, Izumikawa K, Mukae H, Shindo Y, Yamamoto Y, Tateda K, Tomono K, Ishida T, Hasegawa Y, Niki Y, Watanabe A, Soma K, Kohno S.

J Infect Chemother. 2020 Feb;26(2):242-251. doi: 10.1016/j.jiac.2019.08.018. Epub 2019 Sep 28.

10.

Total synthesis of verucopeptin, an inhibitor of hypoxia-inducible factor 1 (HIF-1).

Takahashi N, Hayashi H, Poznaks V, Kakeya H.

Chem Commun (Camb). 2019 Oct 1;55(79):11956-11959. doi: 10.1039/c9cc06169j.

PMID:
31531455
11.

Isolation, Structure Elucidation, and Conformational Regulation of Myropeptins, Lipopeptides from the Fungus Myrothecium roridum.

Yoshimura A, Nishimura S, Suzuki T, Hattori A, Dohmae N, Kato T, Kakeya H.

Org Lett. 2019 Sep 20;21(18):7524-7528. doi: 10.1021/acs.orglett.9b02801. Epub 2019 Sep 9.

PMID:
31497968
12.

Chemical Interactions of Cryptic Actinomycete Metabolite 5-Alkyl-1,2,3,4-tetrahydroquinolines through Aggregate Formation.

Sugiyama R, Nakatani T, Nishimura S, Takenaka K, Ozaki T, Asamizu S, Onaka H, Kakeya H.

Angew Chem Int Ed Engl. 2019 Sep 16;58(38):13486-13491. doi: 10.1002/anie.201905970. Epub 2019 Aug 7. Review.

PMID:
31389661
13.

Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital.

Namikawa H, Yamada K, Sakiyama A, Imoto W, Yamairi K, Shibata W, Yoshii N, Niki M, Nakaie K, Oinuma KI, Tsubouchi T, Niki M, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Diagn Microbiol Infect Dis. 2019 Sep;95(1):84-88. doi: 10.1016/j.diagmicrobio.2019.04.008. Epub 2019 Apr 26.

PMID:
31256940
14.

The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria.

Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Fujimoto H, Nakaie K, Okada Y, Fujita A, Kawaguchi H, Shinoda Y, Nakamura Y, Kaneko Y, Yoshida H, Kakeya H.

J Infect Chemother. 2019 Dec;25(12):1001-1006. doi: 10.1016/j.jiac.2019.05.026. Epub 2019 Jun 26.

PMID:
31255524
15.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
16.

An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.

Furutani Y, Toguchi M, Shiozaki-Sato Y, Qin XY, Ebisui E, Higuchi S, Sudoh M, Suzuki H, Takahashi N, Watashi K, Wakita T, Kakeya H, Kojima S.

PLoS One. 2019 Jun 12;14(6):e0216139. doi: 10.1371/journal.pone.0216139. eCollection 2019.

17.

Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae.

Namikawa H, Oinuma KI, Sakiyama A, Tsubouchi T, Tahara YO, Yamada K, Niki M, Takemoto Y, Miyata M, Kaneko Y, Shuto T, Kakeya H.

Int J Antimicrob Agents. 2019 Aug;54(2):167-175. doi: 10.1016/j.ijantimicag.2019.05.018. Epub 2019 Jun 5.

PMID:
31173862
18.

The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia.

Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, Nakajima K, Mikamo H, Yamagishi Y, Kasahara K, Yoshihara S, Ukimura A, Yoshida K, Yoshinaga N, Izumi M, Kakeya H, Yamada K, Kawamura H, Endou K, Yamanaka K, Yoshioka M, Amino K, Ikeuchi H, Uchino M, Miyazaki Y.

PLoS One. 2019 May 23;14(5):e0216956. doi: 10.1371/journal.pone.0216956. eCollection 2019.

19.

Measurement of Linezolid and Its Metabolites PNU-142300 and PNU-142586 in Human Plasma Using Ultra-Performance Liquid Chromatography Method.

Sakurai N, Nakamura Y, Kawaguchi H, Abe J, Yamada K, Nagayama K, Kakeya H.

Chem Pharm Bull (Tokyo). 2019;67(5):439-444. doi: 10.1248/cpb.c18-00840.

20.

Mortality caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam.

Namikawa H, Yamada K, Yamairi K, Shibata W, Fujimoto H, Takizawa E, Niki M, Nakaie K, Oinuma KI, Niki M, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Diagn Microbiol Infect Dis. 2019 Jul;94(3):287-292. doi: 10.1016/j.diagmicrobio.2019.01.018. Epub 2019 Jan 30.

PMID:
31005401
21.

Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2020 Feb 14;70(5):835-842. doi: 10.1093/cid/ciz287.

PMID:
30959519
22.

Genome-Based Epidemiological Analysis of 13 Acinetobacter Strains Isolated from Blood Cultures of Hospitalized Patients from a University Hospital in Japan.

Oinuma KI, Suzuki M, Nakaie K, Sato K, Saeki K, Sakiyama A, Takizawa E, Niki M, Niki M, Yamada K, Shibayama K, Kakeya H, Kaneko Y.

Jpn J Infect Dis. 2019 Jul 24;72(4):274-280. doi: 10.7883/yoken.JJID.2018.403. Epub 2019 Feb 28.

23.

The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan.

Kawaguchi H, Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Nakaie K, Okada Y, Fujita A, Shinoda Y, Nakamura Y, Kaneko Y, Nagayama K, Kakeya H.

J Infect Chemother. 2019 Jun;25(6):458-462. doi: 10.1016/j.jiac.2019.01.015. Epub 2019 Feb 23.

PMID:
30803878
24.

Erratum to: The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes.

Genpei M, Sunagawa Y, Funamoto M, Shimizu K, Miyazaki Y, Katanasaka Y, Takahashi N, Kakeya H, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2018 Dec;13(2):136. doi: 10.15420/ecr.2018.13.2.ER1.

25.

Identification of the common biosynthetic gene cluster for both antimicrobial streptoaminals and antifungal 5-alkyl-1,2,3,4-tetrahydroquinolines.

Ozaki T, Sugiyama R, Shimomura M, Nishimura S, Asamizu S, Katsuyama Y, Kakeya H, Onaka H.

Org Biomol Chem. 2019 Feb 27;17(9):2370-2378. doi: 10.1039/c8ob02846j.

PMID:
30629078
26.

Development of an anti-hepatitis B virus (HBV) agent through the structure-activity relationship of the interferon-like small compound CDM-3008.

Takahashi N, Hayashi K, Nakagawa Y, Furutani Y, Toguchi M, Shiozaki-Sato Y, Sudoh M, Kojima S, Kakeya H.

Bioorg Med Chem. 2019 Feb 1;27(3):470-478. doi: 10.1016/j.bmc.2018.11.039. Epub 2018 Dec 5.

PMID:
30552008
27.

Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report.

Yamairi K, Ido K, Nakamura S, Niki M, Imoto W, Shibata W, Namikawa H, Fujimoto H, Yamada K, Nakamae H, Hino M, Kaneko Y, Miyazaki Y, Kakeya H.

J Infect Chemother. 2019 Apr;25(4):307-310. doi: 10.1016/j.jiac.2018.10.016. Epub 2018 Nov 30.

PMID:
30503017
28.

The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes.

Genpei M, Sunagawa Y, Funamoto M, Shimizu K, Miyazaki Y, Katanasaka Y, Takahashi N, Kakeya H, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2017 Dec;12(2):107. doi: 10.15420/ecr.2017:23:16. No abstract available. Erratum in: Eur Cardiol. 2018 Dec;13(2):136.

29.

Operative outcomes after laparoscopic splenectomy with special reference to prophylactic antibiotics.

Matsuda T, Kubo S, Ueno M, Takifuji K, Yamaue H, Takemura S, Tanaka S, Shinkawa H, Yamada K, Kakeya H.

Asian J Endosc Surg. 2019 Oct;12(4):380-387. doi: 10.1111/ases.12661. Epub 2018 Nov 8.

PMID:
30411513
30.

Activity-Based Protein Profiling of Non-ribosomal Peptide Synthetases.

Ishikawa F, Tanabe G, Kakeya H.

Curr Top Microbiol Immunol. 2019;420:321-349. doi: 10.1007/82_2018_133. Review.

PMID:
30178264
31.

Theonellamide A, a marine-sponge-derived bicyclic peptide, binds to cholesterol in aqueous DMSO: Solution NMR-based analysis of peptide-sterol interactions using hydroxylated sterol.

Cornelio K, Espiritu RA, Hanashima S, Todokoro Y, Malabed R, Kinoshita M, Matsumori N, Murata M, Nishimura S, Kakeya H, Yoshida M, Matsunaga S.

Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):228-235. doi: 10.1016/j.bbamem.2018.07.010. Epub 2018 Jul 25.

32.

Discovery of Presaccharothriolide X, a Retro-Michael Reaction Product of Saccharothriolide B, from the Rare Actinomycete Saccharothrix sp. A1506.

Lu S, Nishimura S, Takenaka K, Ito M, Kato T, Kakeya H.

Org Lett. 2018 Aug 3;20(15):4406-4410. doi: 10.1021/acs.orglett.8b01535. Epub 2018 Jul 19.

PMID:
30024763
33.

Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes.

Sunagawa Y, Funamoto M, Sono S, Shimizu K, Shimizu S, Genpei M, Miyazaki Y, Katanasaka Y, Morimoto E, Ueno M, Komiyama M, Kakeya H, Wada H, Hasegawa K, Morimoto T.

J Pharmacol Sci. 2018 Apr;136(4):212-217. doi: 10.1016/j.jphs.2017.12.013. Epub 2018 Mar 13.

34.

Successful Treatment of Intestinal Mycosis Caused by a Simultaneous Infection with Lichtheimia ramosa and Aspergillus calidoustus.

Kaneko Y, Oinuma KI, Terachi T, Arimura Y, Niki M, Yamada K, Kakeya H, Mizutani T.

Intern Med. 2018 Aug 15;57(16):2421-2424. doi: 10.2169/internalmedicine.0254-17. Epub 2018 Mar 9.

35.

[National Trends in the Distribution of Candida Species Causing Candidemia in Japan from 2003 to 2014].

Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, Takesue Y, Tomono K, Kadota JI, Kaku M, Miyazaki Y, Kamei K, Shibuya K, Niki Y, Yoshida M, Sei Y.

Med Mycol J. 2018;59(1):E19-E22. doi: 10.3314/mmj.17-00014. Japanese.

36.

A Case of Imported Taenia asiatica Infection in Japan.

Namikawa H, Takemoto Y, Shimazaki I, Makuuchi A, Kobayashi M, Kinuhata S, Yamada K, Fujimoto H, Toyoda H, Kamata N, Tochino Y, Teramoto I, Abe N, Morimura M, Kakeya H, Shuto T.

Jpn J Infect Dis. 2018 Mar 22;71(2):170-171. doi: 10.7883/yoken.JJID.2017.082. Epub 2018 Feb 28. No abstract available.

37.

Clinical Characteristics and Low Susceptibility to Daptomycin in Enterococcus faecium Bacteremia.

Namikawa H, Yamada K, Shibata W, Fujimoto H, Takizawa E, Niki M, Nakaie K, Nakamura Y, Oinuma KI, Niki M, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Tohoku J Exp Med. 2017 Nov;243(3):211-218. doi: 10.1620/tjem.243.211.

38.

Visualizing the Adenylation Activities and Protein-Protein Interactions of Aryl Acid Adenylating Enzymes.

Ishikawa F, Kasai S, Kakeya H, Tanabe G.

Chembiochem. 2017 Nov 16;18(22):2199-2204. doi: 10.1002/cbic.201700361. Epub 2017 Oct 11.

PMID:
28871667
39.

Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood.

Ozawa H, Imaizumi A, Sumi Y, Hashimoto T, Kanai M, Makino Y, Tsuda T, Takahashi N, Kakeya H.

Biol Pharm Bull. 2017;40(9):1515-1524. doi: 10.1248/bpb.b17-00339.

40.

Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study.

Nakamura S, Miyazaki T, Izumikawa K, Kakeya H, Saisho Y, Yanagihara K, Miyazaki Y, Mukae H, Kohno S.

Open Forum Infect Dis. 2017 Jun 19;4(3):ofx129. doi: 10.1093/ofid/ofx129. eCollection 2017 Summer.

41.

A Chemoproteomics Approach to Investigate Phosphopantetheine Transferase Activity at the Cellular Level.

Konno S, Ishikawa F, Suzuki T, Dohmae N, Kakeya H, Tanabe G.

Chembiochem. 2017 Sep 19;18(18):1855-1862. doi: 10.1002/cbic.201700301. Epub 2017 Aug 17.

PMID:
28722191
42.

Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.

Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

Intern Med. 2017;56(14):1807-1815. doi: 10.2169/internalmedicine.56.7702. Epub 2017 Jul 15.

43.

Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.

Yamada K, Namikawa H, Fujimoto H, Nakaie K, Takizawa E, Okada Y, Fujita A, Kawaguchi H, Nakamura Y, Abe J, Kaneko Y, Kakeya H.

Intern Med. 2017;56(7):781-785. doi: 10.2169/internalmedicine.56.7715. Epub 2017 Apr 1.

44.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020.

45.

Identification of a Novel Rhizopus-specific Antigen by Screening with a Signal Sequence Trap and Evaluation as a Possible Diagnostic Marker of Mucormycosis.

Sato K, Oinuma KI, Niki M, Yamagoe S, Miyazaki Y, Asai K, Yamada K, Hirata K, Kaneko Y, Kakeya H.

Med Mycol. 2017 Oct 1;55(7):713-719. doi: 10.1093/mmy/myw146.

PMID:
28199672
46.

Precursor-directed in situ synthesis of Saccharothriolides G and H by the Actinomycete Saccharothrix sp. A1506.

Lu S, Nishimura S, Ito M, Kato T, Kakeya H.

J Antibiot (Tokyo). 2017 May;70(5):718-720. doi: 10.1038/ja.2016.153. Epub 2016 Dec 21. No abstract available.

PMID:
27999442
47.

A chemical proteomic probe for detecting native carrier protein motifs in nonribosomal peptide synthetases.

Kasai S, Ishikawa F, Suzuki T, Dohmae N, Kakeya H.

Chem Commun (Camb). 2016 Dec 1;52(98):14129-14132.

PMID:
27869277
48.

Genome Sequence of an Acinetobacter baumannii Strain Carrying Three Acquired Carbapenemase Genes.

Oinuma KI, Suzuki M, Sato K, Nakaie K, Niki M, Takizawa E, Niki M, Shibayama K, Yamada K, Kakeya H, Kaneko Y.

Genome Announc. 2016 Nov 17;4(6). pii: e01290-16. doi: 10.1128/genomeA.01290-16.

49.

Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome.

Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H.

BMC Infect Dis. 2016 Nov 16;16(1):680.

50.

Effectiveness of weekly polymerase chain reaction-based open reading frame typing analysis of all newly isolated methicillin-resistant Staphylococcus aureus strains for controlling nosocomial infections.

Nakaie K, Yamada K, Park K, Nakamura Y, Okada Y, Fujita A, Fujimoto H, Kaneko Y, Kakeya H.

J Infect Chemother. 2016 Nov;22(11):733-737. doi: 10.1016/j.jiac.2016.07.007. Epub 2016 Sep 28.

Supplemental Content

Loading ...
Support Center